Compare Maravai LifeSciences Holdings Inc. Class A Common Stock (MRVI) vs Upwork Inc (UPWK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Maravai LifeSciences Holdings Inc. Class A Common Stock vs Upwork Inc — how do they compare? Maravai LifeSciences Holdings Inc. Class A Common Stock trades at $6.56 (market cap $977.37M), while Upwork Inc trades at $8.58 (market cap $1.05B). The key difference: Maravai LifeSciences Holdings Inc. Class A Common Stock and Upwork Inc are close in size by market cap, and Maravai LifeSciences Holdings Inc. Class A Common Stock is trading nearer its 52-week high, Upwork Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Maravai LifeSciences Holdings Inc. Class A Common Stock for 0 Days and Upwork Inc for 38 Days on average.
| MRVI | UPWK | |
|---|---|---|
Market Cap | $977.37M | $1.05B |
Volume | 2,742,564 | 2,045,666 |
Sector | Health | Industrials |
52-Week High | $9.00 | $22.11 |
52-Week Low | $2.83 | $7.84 |
Typical Hold Time | 0 Days | 38 Days |
Enterprise Value | $1.08B | $815.52M |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Maravai LifeSciences (MRVI) trades at $6.53, down 7.51% in the last session amid mixed signals. The stock shows improving fundamentals with Q2 2026 revenue growth of 9% and three consecutive earnings beats, though it remains unprofitable with a -37.07% net margin. Technical analysis indicates neutral positioning with key support at $6 and resistance at $7. Recent news highlights patent expansions in China and institutional accumulation.
The outlook remains cautiously optimistic with analyst consensus pointing to 7% upside potential to the $7.00 price target. Key opportunities include margin expansion and RNA technology leadership, while risks center on persistent cash burn and competitive pressures in life sciences. The stock offers speculative growth potential for risk-tolerant investors.
UPWK trades at $8.64, up 0.35% today, with a bullish technical signal from moving averages but neutral oscillators. The company reported Q2 2026 EPS of $0.41, beating expectations, though revenue guidance disappointed. Fundamentals show strong profitability with a 77.21% gross margin and 12.93% net margin, while valuation ratios like P/E of 11.08 and P/S of 1.49 appear reasonable. Recent news includes insider sales and a securities fraud investigation, adding uncertainty.
The outlook is mixed: analyst consensus is a Buy with a $9.64 price target, implying upside, but risks from AI disruption and legal issues persist. Earnings growth and cost management are key catalysts, though competitive pressures and volatile cash flows warrant caution for investors seeking exposure to the freelance marketplace sector.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Maravai LifeSciences Holdings Inc. Class A Common Stock
Maravai LifeSciences Holdings Inc. is a life sciences company supporting drug therapy, diagnostic, and vaccine development through four operating brands: TriLink BioTechnologies (nucleic acid and mRNA synthesis), Cygnus Technologies (biologics safety testing), Glen Research (oligonucleotide synthesis materials), and Alphazyme (enzyme manufacturing). It serves biotech and biopharma customers from discovery through commercial manufacturing.
Read more on MRVI →About Upwork Inc
Upwork Inc is a United States-based company that operates an online marketplace that enables businesses to find and work with highly-skilled independent professionals. The develops platform for hiring and freelancing purposes. Its products offering include Upwork Basic, Upwork Plus, Upwork Business, Upwork Enterprise, and Upwork Payroll. The business generates revenue from Talent and Clients across the USA, India, the Philippines and the rest of the world. Substantial income is derived from providing services to Clients.
Read more on UPWK →
